Advaxis, Inc.(ADXS) - 2022 Q4 - Annual Report
Advaxis, Inc.(US:ADXS)2023-02-10 01:11UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED OCTOBER 31, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______ COMMISSION FILE NUMBER 001-36138 AYALA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) | Delaware | 02-0563870 | | --- | --- | | (State or o ...